|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Prepublished online as a Blood First Edition Paper on November 14, 2002; DOI 10.1182/blood-2002-04-1076.
HEMATOPOIESIS
From the Department of Veterans Affairs Medical Center,
Department of Medicine and Department of Cell Biology and Anatomy,
Medical University of South Carolina, Charleston, SC; and the
Departments of Neurology and Anatomy and Cell Biology, Medical College
of Georgia and the Department of Veterans Affairs Medical Center,
Augusta, GA.
It was recently reported that crude bone marrow cells have the
ability to differentiate into glomerular mesangial cells. However, the
exact nature of the engrafting cells in the bone marrow was not known.
We tested the hypothesis that hematopoietic stem cells are capable of
reconstituting the mesangial cells by transplanting a clonal population
of cells derived from a single stem cell. We cultured
Lin Mesangial cells constitute a population of cells
residing in the glomerular mesangium between the capillary endothelial
cells and the basal membrane of the glomeruli. These irregularly shaped cells possess high levels of actin and myosin and contract upon exposure to a number of vasoactive agents such as angiotensin II.1 It is thought that one of the functions of mesangial
cells is to regulate the blood flow through selected capillary loops. Mesangial cells also are capable of phagocytosis and are involved in a
number of pathologic conditions affecting the kidney. Proliferation of
mesangial cells is associated with IgA nephropathy, mesangial proliferative glomerulonephritis, and diabetic nephropathy. Despite the
pathophysiologic implications, the exact nature and origin of mesangial
cells has not been elucidated. Due to the contractile nature of
these cells, it generally has been held that mesangial cells represent
a specialized type of pericyte. Recently, Imasawa et al2
reported that bone marrow (BM) cells can reconstitute mesangial cells
in the kidney of lethally irradiated mice. However, since crude bone
marrow contains both hematopoietic and nonhematopoietic cells (ie,
stromal cells and capillary endothelial cells), the exact nature of the
cells that engrafted the glomeruli is not known. To test the hypothesis
that mesangial cells are derived from hematopoietic stem cells, we
transplanted a clonal population of cells obtained from a single
hematopoietic stem cell. The results unequivocally establish the
hematopoietic origin of glomerular mesangial cells.
Monoclonal antibodies and hybridomas
Mice
Cell preparation Used as bone marrow donors were 10- to 12-week-old male or female EGFP mice. Used as irradiated recipients and as the source for radioprotective cells were 10- to 14-week-old male or female C57BL/6-Ly5.1 mice. Mice were humanely killed by CO2 inhalation, and BM cells were flushed from femurs and tibiae, pooled, and washed twice with Ca2+-, Mg2+-free phosphate-buffered saline (PBS) (Life Technologies, Grand Island, NY) containing 0.1% bovine serum albumin (BSA) (Sigma-Aldrich, St Louis, MO). Samples were made into single-cell suspensions by repeated pipetting and filtering through a 40-µm nylon mesh. BM cells with densities ranging from 1.063 to 1.077 g/mL were collected by gradient separation using Nycodenz (Accurate Chemical and Scientific, Westbury, NY). Lineage negative (Lin ) BM
cells of EGFP mice were prepared by incubating cells with anti-Mac-1,
anti-Gr-1, anti-B220, anti-CD4, anti-CD8, anti-TER-119, and by removing
positive cells with immunomagnetic beads (Dynabeads M-450 coupled to
sheep anti-rat IgG) (Dynal, Great Neck, NY). The resulting
Lin cells were stained with PE-conjugated anti-Sca-1,
APC-conjugated anti-c-kit, and biotin-conjugated anti-CD34, followed by
streptavidin-conjugated PharRed (Pharmingen). After addition of
propidium iodide at a concentration of 1 µg/mL, the cells were washed
twice, resuspended in PBS containing 0.1% BSA, and kept on ice for
cell sorting. Five-color analysis and cell sorting were performed using
a FACSVantage (Becton Dickinson, San Jose, CA) with appropriate
isotype-matched controls. The Lin cells were first
enriched for the Sca-1+, c-kit+ population.
Single Lin, Sca-1+, c-kit+,
CD34 cells were deposited into round-bottomed 96-well
plates (Corning, Corning, NY) using CloneCyt system (Becton Dickinson).
Single-cell culture To achieve a high efficiency of clonal hematopoietic engraftment, we combined single-cell deposition with short-term cell culture. The culture medium consisted of -modification of Eagle medium (ICN Biomedicals, Aurora, OH), 20% fetal bovine serum (FBS) (Atlanta Biologicals, Norcross, GA), 1% deionized fraction V BSA, 1 × 104 M 2-mercaptoethanol (Sigma-Aldrich),
recombinant rat steel factor (SF), and recombinant human interleukin-11
(IL-11). SF was provided by Amgen (Thousand Oaks, CA) and used at a
concentration of 100 ng/mL. IL-11 (a gift from Genetics Institute,
Cambridge, MA) was used at a concentration of 100 ng/mL. We have
extensive experience with the use of this combination of cytokines in
culture and have observed that it supports maintenance of stem cells
for 1 week.4-6 Corning 96-well plates containing the above
culture media and single cells were incubated at 37°C in a humidified
atmosphere with 5% CO2 in air. At 5 and 18 hours after
single-cell deposition, we carefully inspected all wells of the plates
using an inverted microscope. Eighteen hours after initiation of
culture, single cells were present in approximately 70% of the wells.
The remainders were partially degenerated cells, debris, or cell
doublets. The wells containing single cells were marked and incubated
for a total of 7 days.
Transplantation Recipient Ly-5.1 mice were prepared with a single 950-cGy dose of total body irradiation using a 4 × 106 V linear accelerator. Only contents of the wells containing viable clusters of cells derived from single cells were injected into tail veins of the irradiated Ly-5.1 mice. Five hundred Lin,
Sca-1+, c-kit+, and CD34+ BM cells
from Ly-5.1 mice, which contain only short-term repopulating cells,
were also transplanted as radioprotective cells to prevent posttransplantation death.7 Mice also received 100 noncultured Lin, Sca-1+, c-kit+
CD34 BM cells from EGFP mice in order to exclude the
effect of cell culture on mesangial cell engraftment.
Flow cytometric analysis of hematopoietic engraftment Peripheral blood was obtained from the retro-orbital plexus of the recipient mice 2, 5, and 6 months after transplantation, using heparin-coated micropipettes (Drummond Scientific, Broomall, PA). Red blood cells were lysed with 0.15 M NH4Cl, and the samples were stained with PE-conjugated anti-Ly-5.1. The percentage of chimerism was calculated as (% EGFP+ cells) × 100/(% EGFP+ cells + % Ly-5.1+ cells). Donor-derived cells in T-cell, B-cell, granulocyte, and monocyte/macrophage lineages were analyzed by staining with PE-conjugated anti-Thy-1.2, anti-CD45R/B220, or a combination of anti-Gr-1 and anti-Mac-1, respectively.Histologic analysis of engrafted EGFP+ cells Kidneys from engrafted mice were excised, fixed in 3% paraformaldehyde/PBS solution for 2 hours (25°C), washed, and stored in PBS containing 0.01% sodium azide (PBSA) (4°C). The potential of engrafted EGFP+ cells to contribute to the adult kidney was evaluated by microscopic analysis of thick (vibratome) and thin (paraffin) sections. Vibratome sections (30-100 µm) were cut using an OTS-3000 vibratome (Electron Microscopy Sciences, Fort Washington, PA). Briefly, fixed tissue was gently dried with a paper towel, mounted onto a sectioning stage using instant-drying glue, submerged in PBSA, and sectioned. For paraffin sections, the fixed tissue was dehydrated through a graded series of ethanol/water solutions (30%, 50%, 80%, and 100%) for 10 minutes each. The tissue was infiltrated with 100% Histo-Clear (National Diagnostics, Atlanta, GA) for 2 hours and then processed through a graded series of Histo-Clear:paraffin solutions (3:1, 1:1, 1:3) for 15 minutes each. Finally, the tissue was infiltrated with 100% paraffin for 1 hour twice, embedded in fresh paraffin, cut into 7- to 10-µm sections using a Spencer microtome, floated onto glass slides, and allowed to dry over low heat. Sections were then cleared using Histo-Clear (3 × 10 minutes), rehydrated through a graded series of ethanol/water solutions (100%, 80%, 50%, and 30%) for 10 minutes each, and, finally, transferred into PBSA. Both vibratome and paraffin sections were mounted on glass slides under no. 0 cover slips (Fisher Scientific, Sewanee, GA) using an antiphotobleaching mounting medium. EGFP+ cells were imaged using a Leica DMR light microscope equipped with epifluorescence and differential interference contrast (DIC) optics (Vashaw Scientific, Norcross, GA). Images were processed using Adobe Photoshop 5.5 software (Adobe Systems, San Jose, CA).Contractile response to angiotensin II in culture To extend upon our histologic designation of the engrafted cells as mesangial cells, we next evaluated the ability of the cells to respond to a factor (angiotensin II) that is known to elicit a biologic response in mesangial cells.1 To conduct this experiment we established mesangial cell cultures. Briefly, the cultures were generated as follows. Kidneys from engrafted animals were surgically removed and the cortex separated from the medulla. Cortexes were placed in sterile RPMI-1640 medium (Mediatech, Herndon, VA) and cut into 1- to 2-mm3 pieces. The glomeruli were then separated from the cortex by sequential mechanical sieving as previously described.8 Isolated glomeruli were plated on chamber slides coated with collagen I (BIOCOAT culture slides; Falcon, Becton Dickinson Labware, Mountain View, CA) and cultured in RPMI-1640 medium containing 15% FBS, 100 µg/mL streptomycin, 100 units/mL penicillin, and 2 mM L-glutamine. Media were replaced every 48 hours.After the cells reached a near-confluent state (about 2 weeks), they
were washed once with serum-free RPMI-1640 and then imaged using a
Leica DMR upright microscope equipped with DIC and epifluorescence optics. EGFP+ cells were selected and photographed prior to
the administration of angiotensin II (Sigma-Aldrich) using both
epifluorescence and DIC optics. The cells were then exposed to
10 Fluorescence in situ hybridization (FISH) analysis of Y-chromosome In order to exclude the possibility that cell fusions caused the apparent plasticity of stem cells, we carried out male-to-male transplantation and performed FISH for Y-chromosome analysis of EGFP+ mesangial cells. Paraformaldehyde-fixed, paraffin-embedded kidney sections from the mouse that received a transplant were labeled with a Y-chromosome paint probe and Cy3-labeled GFP antibody as previously described.9 Briefly, paraffin-embedded sections were deparaffinized, hydrated to 70% ethanol, serially dehydrated, and reacted with biotinylated Y-chromosome paint probe (catalog No. BMPOY; Applied Genetics Laboratories, Melbourne, FL). The biotinylated paint probe was detected with fluorescein isothiocyanate (FITC)-conjugated streptavidin (Jackson Immunoresearch Laboratories, West Grove, PA). EGFP+ cells were identified by a primary antibody, AF594-rabbit anti-GFP (no. A-21312; Molecular Probes, Eugene, OR), followed by Cy3-labeled affinity-purified F(ab')2 fragments of donkey anti-rabbit IgG (H+L) (Jackson Immunoresearch Laboratories). Nuclei were counterstained with bis-benzimide (Sigma-Aldrich). Sections were coverslipped with Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and viewed with a Zeiss Axioplan 2 microscope (Thornwood, NY). Images were captured with a Spot II CCD digital camera (Diagnostic Instruments, Sterling Heights, MI).
In order to efficiently generate mice that exhibit a
high-level of hematopoietic reconstitution from a single
EGFP+ stem cell, we have combined single-cell deposition on
FACSVantage and cell culture. Clonal populations of cells derived from
single hematopoietic stem cells were then transplanted into lethally irradiated recipient mice, Analysis of the nucleated blood
cells from these mice 2 to 6 months later revealed variable levels of hematopoietic chimerism and lineage combinations. Presented in Figure
1 is the flow cytometric analysis of the
nucleated blood cells from a recipient mouse exhibiting a high level
(about 90%) of multilineage engraftment 2 months after
transplantation. Myeloid and lymphoid chimerism was seen, although
macrophage/monocyte and granulocyte engraftment was predominant. The
engrafting T cells appeared to consist of 2 populations as reported by
Okabe et al.3
Five mice exhibiting high levels (60%-90%) of multilineage
engraftment were killed and their kidneys examined microscopically. Analysis of vibratome and paraffin sections from each of the mice revealed an identical pattern of engraftment by EGFP+ cells
into the kidney. Images depicted in Figure
2 are composite DIC and epifluorescence
images of kidney sections from engrafted animals. When vibratome
sections were viewed at low magnification, a population of
EGFP+ cells was consistently observed in the glomeruli
(Figure 2A). Analysis of sections at higher magnification revealed that
the EGFP+ cells had a morphology characteristic of
mesangial cells (Figure 2B). The evidence that the EGFP+
cells were indeed mesangial cells is supported by analysis of serial
thin sections of engrafted kidneys. Figure 2C is a representative image
from such a series. The cytoplasmic distribution of green fluorescent
protein revealed an irregular shape and compact morphology of the cells
lacking large cellular processes. This compact morphology clearly
distinguishes these cells from podocytes, which have a highly branched
morphology.
It was possible that the ability of the hematopoietic stem cells to
generate mesangial cells was an artifact of culture and that
hematopoietic stem cells do not possess the inherent capacity to
differentiate into mesangial cells. In order to test this premise, we
transplanted 100 noncultured Lin Although the location and the morphology of the cells strongly
suggested that these cells were mesangial cells, we carried out cell
culture experiments to evaluate the ability of these cells to respond
to a known mesangial cell vasoactive agent (angiotensin II). Only
mesangial cells, but not epithelial or endothelial cells, in the
glomeruli contract upon exposure to angiotensin II.1 Depicted in Figure 3 are composite DIC
and epifluorescence images of a representative cultured
EGFP+ cell taken prior to the administration of angiotensin
II (Figure 3A) and 10 minutes after exposure to angiotensin II (Figure
3B). The horizontal lines crossing the images are provided as reference points to illustrate the contractile response of the cells. Most of the
EGFP+ cells contracted upon exposure to angiotensin II.
Recently, investigators in 2 laboratories observed spontaneous
fusions between EGFP+ ES cells and somatic cells and
together with authors of a number of commentaries, suggested that some
of the data describing stem cell plasticity, including those based on
transplantation, may be the result of spontaneous cell
fusions.10,11 In order to exclude this possibility, we
performed male-to-male transplantation and performed FISH for
Y-chromosome analysis of EGFP+ mesangial cells by using a
Y-chromosome paint probe and anti-GFP antibody (Figure
4). Three independent reviewers analyzed
70-80 EGFP+ cells and found only a single Y-chromosome in
each cell. This observation negated the possibility that the
EGFP+ mesangial cells that we observed in the clonally
engrafted mice are generated by spontaneous cell fusion.
Imasawa et al2 carried out time course analysis of the development of mesangial cells from bone marrow cells and noted the emergence of mesangial cells as early as 2 weeks after transplantation. We observed mesangial cells in all clonally engrafted mice at 2, 5, and 6 months after transplantation. Although the numbers and populations of bone marrow cells transplanted and the doses of radiation to the recipient mice differ between the 2 studies, the relative ease with which the mesangial cells were generated in both studies suggests rapid turnover of mesangial cells. In support of this is the estimate of 1% daily renewal made by Pabst and Sterzel.12 Although we observed mesangial cells in all 5 mice revealing clonal hematopoietic engraftment, these numbers are too small to answer the question of whether or not all hematopoietic stem cells are capable of generating mesangial cells. Analysis of kidneys from mice receiving transplants of paired progenies of stem cells is in progress to examine the mechanisms of stem cell commitment to the mesangial cell lineage. Recently, Wagers et al13 examined organs of mice
given transplants of single hematopoietic stem cells and did not report the presence of donor-origin glomerular mesangial cells. However, our
methods of stem cell purification are slightly different. Of
Lin All circulating blood cells, including myeloid cells, lymphocytes, and platelets are derived from hematopoietic stem cells. In addition, hematopoietic stem cells are a source of tissue-residing cells such as mast cells, liver Kupffer cells, and osteoclasts. In this paper, we extended upon the recent observation of Imasawa et al2 that suggested a bone marrow origin of glomerular mesangial cells and clearly established that hematopoietic stem cells give rise to glomerular mesangial cells. This concept may be important in the development of therapies for a number of kidney diseases that display mesangial cell hyperproliferation.
The authors thank Anne G. Livingston and Amanda C. LaRue for assistance in preparation of this manuscript, and the staff of the Radiation Oncology Department of the Medical University of South Carolina for assistance in the irradiation of mice.
Submitted April 8, 2002; accepted October 18, 2002.
Prepublished online as Blood First Edition Paper, November 14, 2002; DOI 10.1182/blood-2002-04-1076.
Supported by National Institutes of Health grants RO1-HL57375, RO1-HL52813, DAMD 17-00-1-0338, RO1-DK54197, PO1-CA78582; by American Heart Association, Southeast Affiliate; and by the Office of Research and Development, Medical Research Services, Department of Veterans Affairs.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Makio Ogawa, Department of Veterans Affairs Medical Center, 109 Bee St, Charleston, SC 29401-5799; e-mail: ogawam{at}musc.edu.
1. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, Striker GE. Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int. 1988;33:677-684[Medline] [Order article via Infotrieve].
2.
Imasawa T, Utsunomiya Y, Kawamura T, et al.
The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells.
J Am Soc Nephrol.
2001;12:1401-1409 3. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319[CrossRef][Medline] [Order article via Infotrieve].
4.
Yonemura Y, Ku H, Lyman SD, Ogawa M.
In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand.
Blood.
1997;89:1915-1921
5.
Sato T, Laver JH, Ogawa M.
Reversible expression of CD34 by murine hematopoietic stem cells.
Blood.
1999;94:2548-2554
6.
Tajima F, Deguchi T, Laver JH, Zeng H, Ogawa M.
Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells.
Blood.
2001;97:2618-2624 7. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-245[Abstract].
8.
Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, Gilkeson GS.
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.
J Immunol.
2000;164:1498-1504
9.
Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, Carothers J.
Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke.
Stroke.
2002;33:1362-1368 10. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545[CrossRef][Medline] [Order article via Infotrieve]. 11. Ying Q-L, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002;416:545-548[CrossRef][Medline] [Order article via Infotrieve]. 12. Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats: an autoradiographic analysis. Kidney Int. 1983;24:624-631.
13.
Wagers AJ, Sherwood RI, Christenson JL, Weissman IL.
Little evidence for developmental plasticity of adult hematopoietic stem cells.
Science.
2002;297:2256-2259 14. Schreiner GF, Unaue ER. Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest. 1984;51:515-523[Medline] [Order article via Infotrieve].
© 2003 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  E. C.W. Hung, T. K.F. Shing, S. S.C. Chim, P. C. Yeung, R. W.Y. Chan, K. W. Chik, V. Lee, N. B.Y. Tsui, C.-K. Li, C. S.C. Wong, et al. Presence of Donor-Derived DNA and Cells in the Urine of Sex-Mismatched Hematopoietic Stem Cell Transplant Recipients: Implication for the Transrenal Hypothesis Clin. Chem., April 1, 2009; 55(4): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Quaggin and J. A. Kreidberg Development of the renal glomerulus: good neighbors and good fences Development, February 15, 2008; 135(4): 609 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Miyata, M. Masuya, S. Yoshida, S. Nakamura, K. Kato, Y. Sugimoto, T. Shibasaki, K. Yamamura, K. Ohishi, K. Nishii, et al. Hematopoietic origin of hepatic stellate cells in the adult liver Blood, February 15, 2008; 111(4): 2427 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Stokman, J. C. Leemans, I. Stroo, I. Hoedemaeker, N. Claessen, G. J. D. Teske, J. J. Weening, and S. Florquin Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis Nephrol. Dial. Transplant., February 1, 2008; 23(2): 483 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Vaughan and S. E. Quaggin How Do Mesangial and Endothelial Cells Form the Glomerular Tuft? J. Am. Soc. Nephrol., January 1, 2008; 19(1): 24 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tongers and D. W. Losordo Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2843 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Terrier, Y. Delmas, A. Hummel, C. Presne, F. Glowacki, B. Knebelmann, C. Combe, P. Lesavre, N. Maillard, L.-H. Noel, et al. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1369 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ogawa, A. C. LaRue, and C. J. Drake Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications Blood, November 1, 2006; 108(9): 2893 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Eisenberg, J. B.E. Burch, and L. M. Eisenberg Bone Marrow Cells Transdifferentiate to Cardiomyocytes When Introduced into the Embryonic Heart Stem Cells, May 1, 2006; 24(5): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Visconti, Y. Ebihara, A. C. LaRue, P. A. Fleming, T. C. McQuinn, M. Masuya, H. Minamiguchi, R. R. Markwald, M. Ogawa, and C. J. Drake An In Vivo Analysis of Hematopoietic Stem Cell Potential: Hematopoietic Origin of Cardiac Valve Interstitial Cells Circ. Res., March 17, 2006; 98(5): 690 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Perry, S. Tam, K. Zheng, Y. Sado, H. Dobson, B. Jefferson, R. Jacobs, and P. S. Thorner Type IV Collagen Induces Podocytic Features in Bone Marrow Stromal Stem Cells In Vitro J. Am. Soc. Nephrol., January 1, 2006; 17(1): 66 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yokota, Y. Kawakami, Y. Nagai, J.-x. Ma, J.-Y. Tsai, P. W. Kincade, and S. Sato Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type {alpha}-Actin-Expressing Cells Stem Cells, January 1, 2006; 24(1): 13 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Feng, A. R. Plati, Q.-l. Cheng, M. Berho, A. Banerjee, M. Potier, W.-c. Jy, A. Koff, L. J. Striker, and G. E. Striker Glomerular Aging in Females Is a Multi-Stage Reversible Process Mediated by Phenotypic Changes in Progenitors Am. J. Pathol., August 1, 2005; 167(2): 355 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Stokman, J. C. Leemans, N. Claessen, J. J. Weening, and S. Florquin Hematopoietic Stem Cell Mobilization Therapy Accelerates Recovery of Renal Function Independent of Stem Cell Contribution J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1684 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Fang, M. R. Alison, H. T. Cook, R. Jeffery, N. A. Wright, and R. Poulsom Proliferation of Bone Marrow-Derived Cells Contributes to Regeneration after Folic Acid-Induced Acute Tubular Injury J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1723 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schachinger and A. M. Zeiher Stem Cells and Cardiovascular and Renal Disease: Today and Tomorrow J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S2 - S6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Szczypka, A. J. Westover, S. G. Clouthier, J. L.M. Ferrara, and H. D. Humes Rare Incorporation of Bone Marrow-Derived Cells Into Kidney After Folic Acid-Induced Injury Stem Cells, January 1, 2005; 23(1): 44 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jiang, L. Walker, M. Afentoulis, D. A. Anderson, L. Jauron-Mills, C. L. Corless, and W. H. Fleming Transplanted human bone marrow contributes to vascular endothelium PNAS, November 30, 2004; 101(48): 16891 - 16896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zheng, F. Cornacchia, I. Schulman, A. Banerjee, Q.-l. Cheng, M. Potier, A. R. Plati, M. Berho, S. J. Elliot, J. Li, et al. Development of Albuminuria and Glomerular Lesions in Normoglycemic B6 Recipients of db/db Mice Bone Marrow: The Role of Mesangial Cell Progenitors Diabetes, September 1, 2004; 53(9): 2420 - 2427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Togel, J. Isaac, and C. Westenfelder Hematopoietic Stem Cell Mobilization-Associated Granulocytosis Severely Worsens Acute Renal Failure J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1261 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Prindull and D. Zipori Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm Blood, April 15, 2004; 103(8): 2892 - 2899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Alison, R Poulsom, W R Otto, P Vig, M Brittan, N C Direkze, M Lovell, T C Fang, S L Preston, and N A Wright Recipes for adult stem cell plasticity: fusion cuisine or readymade? J. Clin. Pathol., February 1, 2004; 57(2): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maeshima, S. Yamashita, and Y. Nojima Identification of Renal Progenitor-Like Tubular Cells that Participate in the Regeneration Processes of the Kidney J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3138 - 3146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Herzog, L. Chai, and D. S. Krause Plasticity of marrow-derived stem cells Blood, November 15, 2003; 102(10): 3483 - 3493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Korbling and Z. Estrov Adult Stem Cells for Tissue Repair -- A New Therapeutic Concept? N. Engl. J. Med., August 7, 2003; 349(6): 570 - 582. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
